Pancreaticoduodenectomy with Extended Retroperitoneal Lymphadenectomy for Periampullary Adenocarcinoma

Surgical Oncology Clinics of North America

Volumn 16, Issue 1, 2007, Pages 157-176

  Kennedy, Eugene P ^a   Yeo, Charles J ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; CANCER SURGERY; CANCER SURVIVAL; FEMALE; HUMAN; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; PANCREAS ADENOCARCINOMA; PANCREATICODUODENECTOMY; POSTOPERATIVE COMPLICATION; REVIEW; SURGICAL TECHNIQUE;

ADENOCARCINOMA; AMPULLA OF VATER; COMMON BILE DUCT NEOPLASMS; GASTRECTOMY; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; RETROPERITONEAL SPACE; SURVIVAL ANALYSIS;

EID: 33847274809     PISSN: 10553207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.soc.2006.10.010     Document Type: Review

References (49)

1. U.S. Cancer Statistics Working Group. United States cancer statistics: 1999-2002 incidence and mortality web-based report. Available at: www.cdc.gov/cancer/npcr/uscs. Accessed February 2, 2006.
2. Geer R.J., and Brennan M.F. Prognostic indicators for survival after resection of pancreatic adenocarcinoma. Am J Surg 165 (1993) 68-72 [discussion: 72-3]
3. Conlon K.C., Klimstra D.S., and Brennan M.F. Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5-year survivors. Ann Surg 223 (1996) 273-279
4. Sohn T.A., Yeo C.J., Cameron J.L., et al. Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators. J Gastrointest Surg 4 (2000) 567-579
5. Yeo C.J., Sohn T.A., Cameron J.L., et al. Periampullary adenocarcinoma: analysis of 5-year survivors. Ann Surg 227 (1998) 821-831
6. Yeo C.J., and Cameron J.L. Prognostic factors in ductal pancreatic cancer. Langenbecks Arch Surg 383 (1998) 129-133
7. Delcore R., Rodriguez F.J., Forster J., et al. Significance of lymph node metastases in patients with pancreatic cancer undergoing curative resection. Am J Surg 172 (1996) 463-468 [discussion: 468-9]
8. Nakeeb A., Pitt H.A., Sohn T.A., et al. Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg 224 (1996) 463-473 [discussion: 473-5]
9. Allison D.C., Piantadosi S., Hruban R.H., et al. DNA content and other factors associated with ten-year survival after resection of pancreatic carcinoma. J Surg Oncol 67 (1998) 151-159
10. Tascilar M., Skinner H.G., Rosty C., et al. The SMAD4 protein and prognosis of pancreatic ductal adenocarcinoma. Clin Cancer Res 7 (2001) 4115-4121
11. Montgomery R.C., Hoffman J.P., Riley L.B., et al. Prediction of recurrence and survival by post-resection CA 19-9 values in patients with adenocarcinoma of the pancreas. Ann Surg Oncol 4 (1997) 551-556
12. Yeo C.J., Abrams R.A., Grochow L.B., et al. Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience. Ann Surg 225 (1997) 621-633 [discussion: 633-6]
13. Neoptolemos J.P., Dunn J.A., Stocken D.D., et al. Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial. Lancet 358 (2001) 1576-1585
14. Nukui Y., Picozzi V.J., and Traverso L.W. Interferon-based adjuvant chemoradiation therapy improves survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. Am J Surg 179 (2000) 367-371
15. Klinkenbijl J.H., Jeekel J., Sahmoud T., et al. Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group. Ann Surg 230 (1999) 776-782 [discussion: 782-4]
16. Halsted W.S. Contribution to the surgery of the bile passages, especially of the common bile-duct. Boston Medical and Surgical Journal 141 (1899) 645-654
17. Whipple A.O. Observations on radical surgery for lesions of the pancreas. Surg Gyn Obst 82 (1946) 62
18. Howard J.M. Pancreatico-duodenectomy: forty-one consecutive Whipple resections without an operative mortality. Ann Surg 168 (1968) 629-640
19. Fortner J.G. Regional resection of cancer of the pancreas: a new surgical approach. Surgery 73 (1973) 307-320
20. Fortner J.G. Recent advances in pancreatic cancer. Surg Clin North Am 54 (1974) 859-863
21. Fortner J.G., Kim D.K., Cubilla A., et al. Regional pancreatectomy: en bloc pancreatic, portal vein and lymph node resection. Ann Surg 186 (1977) 42-50
22. Fortner J.G., Klimstra D.S., Senie R.T., et al. Tumor size is the primary prognosticator for pancreatic cancer after regional pancreatectomy. Ann Surg 223 (1996) 147-153
23. Cubilla A.L., Fortner J., and Fitzgerald P.J. Lymph node involvement in carcinoma of the head of the pancreas area. Cancer 41 (1978) 880-887
24. Kayahara M., Nagakawa T., Ueno K., et al. Surgical strategy for carcinoma of the pancreas head area based on clinicopathologic analysis of nodal involvement and plexus invasion. Surgery 117 (1995) 616-623
25. Ishikawa O., Ohigashi H., Sasaki Y., et al. Practical grouping of positive lymph nodes in pancreatic head cancer treated by an extended pancreatectomy. Surgery 121 (1997) 244-249
26. Satake K., Nishiwaki H., Yokomatsu H., et al. Surgical curability and prognosis for standard versus extended resection for T1 carcinoma of the pancreas. Surg Gynecol Obstet 175 (1992) 259-265
27. Manabe T., Ohshio G., Baba N., et al. Radical pancreatectomy for ductal cell carcinoma of the head of the pancreas. Cancer 64 (1989) 1132-1137
28. McFadden D.W., and Reber H.A. Cancer of the pancreas: radical resection-supporting view. Adv Surg 27 (1994) 257-272
29. Pancreas Club Inc. Extended lymphadenectomy during pancreaticoduodenectomy for cancer of the pancreas: summary of "how I do it" session. J Gastrointest Surg 4 (2000) 225-232
30. Henne-Bruns D., Vogel I., Luttges J., et al. Surgery for ductal adenocarcinoma of the pancreatic head: staging, complications, and survival after regional versus extended lymphadenectomy. World J Surg 24 (2000) 595-601 [discussion: 601-2]
31. Pedrazzoli S., DiCarlo V., Dionigi R., et al. Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: a multicenter, prospective, randomized study. Lymphadenectomy study group. Ann Surg 228 (1998) 508-517
32. Farnell M.B., Pearson R.K., Sarr M.G., et al. A prospective randomized trial comparing standard pancreatoduodenectomy with pancreatoduodenectomy with extended lymphadenectomy in resectable pancreatic head adenocarcinoma. Surgery 138 (2005) 618-628 [discussion: 628-30]
33. Nimura Y., Nagino M., Kato H., et al. Regional versus extended lymph node dissection in radical pancreaticoduodenectomy for pancreatic cancer: a multicenter, randomized controlled trial. HPB Surg 6 Suppl 1 (2004) 2
34. Seiler C.A., Wagner M., Bachmann T., et al. Randomized clinical trial of pylorus-preserving duodenopancreatectomy versus classical Whipple resection-long term results. Br J Surg 92 (2005) 547-556
35. Yeo C.J., Cameron J.L., Sohn T.A., et al. Pancreaticoduodenectomy with or without extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma: comparison of morbidity and mortality and short-term outcome. Ann Surg 229 (1999) 613-622 [discussion: 622-4]
36. Yeo C.J., Cameron J.L., Lillemoe K.D., et al. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality. Ann Surg 236 (2002) 355-366 [discussion: 366-8]
37. Riall T.S., Cameron J.L., Lillemoe K.D., et al. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma-part 3: update on 5-year survival. J Gastrointest Surg 9 (2005) 1191-1204 [discussion: 1204-6]
38. Abrams R.A., Grochow L.B., Chakravarthy A., et al. Intensified adjuvant therapy for pancreatic and periampullary adenocarcinoma: survival results and observations regarding patterns of failure, radiotherapy dose and CA19-9 levels. Int J Radiat Oncol Biol Phys 44 (1999) 1039-1046
39. Chakravarthy A., Abrams R.A., Yeo C.J., et al. Intensified adjuvant combined modality therapy for resected periampullary adenocarcinoma: acceptable toxicity and suggestion of improved 1-year disease-free survival. Int J Radiat Oncol Biol Phys 48 (2000) 1089-1096
40. Jaffee E.M., Abrams R., Cameron J., et al. A phase I clinical trial of lethally irradiated allogeneic pancreatic tumor cells transfected with the GM-CSF gene for the treatment of pancreatic adenocarcinoma. Hum Gene Ther 9 (1998) 1951-1971
41. Jaffee E.M., Hruban R.H., Biedrzycki B., et al. Novel allogeneic granulocyte-macrophage colony-stimulating factor-secreting tumor vaccine for pancreatic cancer: a phase I trial of safety and immune activation. J Clin Oncol 19 (2001) 145-156
42. Huang J.J., Yeo C.J., Sohn T.A., et al. Quality of life and outcomes after pancreaticoduodenectomy. Ann Surg 231 (2000) 890-898
43. Wenger F.A., Jacobi C.A., Haubold K., et al. Gastrointestinal quality of life after duodenopancreatectomy in pancreatic carcinoma. Preliminary results of a prospective randomized study: pancreatoduodenectomy or pylorus-preserving pancreatoduodenectomy. Chirurg 70 (1999) 1454-1459
44. Kokoska E.R., Stapleton D.R., Virgo K.S., et al. Quality of life measurements do not support palliative pancreatic cancer treatments. Int J Oncol 13 (1998) 1323-1329
45. Melvin W.S., Buekers K.S., Muscarella P., et al. Outcome analysis of long-term survivors following pancreaticoduodenectomy. J Gastrointest Surg 2 (1998) 72-78
46. Patel A.G., Toyama M.T., Kusske A.M., et al. Pylorus-preserving Whipple resection for pancreatic cancer. Is it any better?. Arch Surg 130 (1995) 838-842 [discussion: 842-3]
47. McLeod R.S., Taylor B.R., O'Connor B.I., et al. Quality of life, nutritional status, and gastrointestinal hormone profile following the Whipple procedure. Am J Surg 169 (1995) 179-185
48. Nguyen T.C., Sohn T.A., Cameron J.L., et al. Standard vs. radical pancreaticoduodenectomy for periampullary adenocarcinoma: a prospective, randomized trial evaluating quality of life in pancreaticoduodenectomy survivors. J Gastrointest Surg 7 (2003) 1-9 [discussion: 9-11]
49. Pisters P.W., Evans D.B., Leung D.H., et al. Re: surgery for ductal adenocarcinoma of the pancreatic head. World J Surg 25 (2001) 533-534